info@luxdx.com (229) 442-7210 Client Portal
LUX Therapeutics
Transforming Healthcare, Restoring Life
LUX Therapeutics empowers healthcare providers to enhance healing with innovative Regenerative medicine.
We process high-quality tissue allograft products to support and help stimulate the human body’s innate repair mechanisms. Accelerated self-healing improves patient outcomes and their quality of life.
What Is Regenerative Medicine?
Our approach to Regenerative medicine builds on the body’s natural ability to heal itself by using re-purposed human tissue to help accelerate healing and slow cellular degeneration.
Specifically, our regenerative products use allografts to support regrowth, repair, or replace damaged or diseased tissue. The products include injectable and topical suspensions customized to support healing.
About us
LUX Therapeutics is an innovative biotechnology company specializing in the development and production of tissue allograft products used in regenerative medicine. As experts in multiple disciplines, we focus on science-based, clinically established, and personalized regenerative therapies.
LUX Therapeutics Products
Luxegen™ (L)
Luxegen A tissue allograft product derived from minimally manipulated umbilical cord tissue and consists mainly perivascular and collagen fibers, cytokines, growth factors, mesenchymal stem cells, etc…
Theramend™ (L)
The Theramend patch is a minimally processed dehydrated amniotic membrane that is used as a protective wound covering to support healing of wounds. TM contains repair and regenerative factors…
Patients
Lux Therapeutics is dedicated to advancing the field, developing cutting-edge technologies, and training the next generation of regenerative medicine leaders.
PROVIDERS
If you are a clinic or physician, please do not hesitate to contact us. Click below to submit your contact information and a representative will reach out shortly.
LUX THERAPEUTICS IS AN FDA REGISTERED AND INSPECTED TISSUE BANK WHICH adheres to ALL GOOD TISSUE PRACTICE GUIDELINES outlined iN FDA 21 CFR 1271 OF THE PHS ACT.
Get in touch
Call us
Write us
Visit us
"*" indicates required fields